(11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one

C34H36F2N6O5S — CID 163244683

IUPAC(11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
SMILESCc1cccc(C)c1-c1cc2nc(n1)NS(=O)(=O)c1cccc(c1)C(=O)N(Cc1ncc(OC3CC(F)(F)C3)cn1)[C@H](CC(C)C)CO2
InChIInChI=1S/C34H36F2N6O5S/c1-20(2)11-24-19-46-30-13-28(31-21(3)7-5-8-22(31)4)39-33(40-30)41-48(44,45)27-10-6-9-23(12-27)32(43)42(24)18-29-37-16-26(17-38-29)47-25-14-34(35,36)15-25/h5-10,12-13,16-17,20,24-25H,11,14-15,18-19H2,1-4H3,(H,39,40,41)/t24-/m1/s1
InChIKeyUCUSWISZUDGFHX-XMMPIXPASA-N
MW678.76 g/mol
LogP5.98
Rot. Bonds7

About (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one

(11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one (PubChem CID 163244683) has the molecular formula C34H36F2N6O5S and a molecular weight of 678.76 g/mol. Its IUPAC name is (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one.

Molecular Properties

Compound Name(11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
PubChem CID163244683
Molecular FormulaC34H36F2N6O5S
Molecular Weight678.76 g/mol
Exact Mass678.24
IUPAC Name(11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
SMILESCc1cccc(C)c1-c1cc2nc(n1)NS(=O)(=O)c1cccc(c1)C(=O)N(Cc1ncc(OC3CC(F)(F)C3)cn1)[C@H](CC(C)C)CO2
InChIInChI=1S/C34H36F2N6O5S/c1-20(2)11-24-19-46-30-13-28(31-21(3)7-5-8-22(31)4)39-33(40-30)41-48(44,45)27-10-6-9-23(12-27)32(43)42(24)18-29-37-16-26(17-38-29)47-25-14-34(35,36)15-25/h5-10,12-13,16-17,20,24-25H,11,14-15,18-19H2,1-4H3,(H,39,40,41)/t24-/m1/s1
InChIKeyUCUSWISZUDGFHX-XMMPIXPASA-N
XLogP5.98
TPSA136.50 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms48
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500678.76
LogP ≤ 55.98
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
The IUPAC name of (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one (CID 163244683) is (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one.
What is the SMILES notation for (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
The canonical SMILES for (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one is Cc1cccc(C)c1-c1cc2nc(n1)NS(=O)(=O)c1cccc(c1)C(=O)N(Cc1ncc(OC3CC(F)(F)C3)cn1)[C@H](CC(C)C)CO2.
What is the InChIKey of (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
The InChIKey is UCUSWISZUDGFHX-XMMPIXPASA-N. The full InChI is InChI=1S/C34H36F2N6O5S/c1-20(2)11-24-19-46-30-13-28(31-21(3)7-5-8-22(31)4)39-33(40-30)41-48(44,45)27-10-6-9-23(12-27)32(43)42(24)18-29-37-16-26(17-38-29)47-25-14-34(35,36)15-25/h5-10,12-13,16-17,20,24-25H,11,14-15,18-19H2,1-4H3,(H,39,40,41)/t24-/m1/s1.
What are the key properties of (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
(11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one has a molecular weight of 678.76 g/mol, XLogP of 5.98, 7 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (11R)-12-[[5-(3,3-difluorocyclobutyl)oxypyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one is sourced from PubChem (CID 163244683), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).